Literature DB >> 10861877

Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.

H Lyng1, O Haraldseth, E K Rofstad.   

Abstract

The aim of this study was to investigate whether apparent diffusion coefficients (ADCs) could be used as measures of cell density and necrotic fraction of tumors. Tumors of four human melanoma xenograft lines were subjected to diffusion-weighted magnetic resonance imaging (DWI). ADCs were calculated from the images and related to cell density and necrotic fraction, as determined from histological sections. A significant correlation was found between the ADC of the viable tissue and cell density, regardless of whether tumors of different lines or different regions within individual tumors were considered. Necrosis was found in two of the lines. A single region of massive necrosis that could be differentiated from the viable tissue in ADC maps was found in one line, whereas a number of smaller necrotic regions that could not be identified in ADC maps were found in the other line. Tumor ADC was significantly correlated with the necrotic fraction of the former, but not of the latter line. Our results suggest that ADCs can be used as measures of cell density and necrotic fraction of some but not of all tumors, depending on whether the individual necrotic regions are large enough to be differentiated from the viable tissue with the obtained spatial resolution of the DW images. Magn Reson Med 43:828-836, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861877     DOI: 10.1002/1522-2594(200006)43:6<828::aid-mrm8>3.0.co;2-p

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  167 in total

1.  Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Taryar Zaw; Albert Lai; Phioanh L Nghiemphu; Robert Harris; Shadi Lalezari; Naveed Wagle; Kourosh M Naeini; Jose Carrillo; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-01-22       Impact factor: 12.300

Review 2.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

3.  Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy.

Authors:  Piotr Kozlowski; Silvia D Chang; Ran Meng; Burkhard Mädler; Robert Bell; Edward C Jones; S Larry Goldenberg
Journal:  Magn Reson Imaging       Date:  2010-04-13       Impact factor: 2.546

4.  Changes in apparent diffusion coefficients in the normal uterus during different phases of the menstrual cycle.

Authors:  A Kido; M Kataoka; T Koyama; A Yamamoto; T Saga; K Togashi
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

Review 5.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

6.  Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.

Authors:  Daniel C Colvin; Mary E Loveless; Mark D Does; Zou Yue; Thomas E Yankeelov; John C Gore
Journal:  Magn Reson Imaging       Date:  2010-12-28       Impact factor: 2.546

7.  Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy.

Authors:  Nkiruka C Atuegwu; Lori R Arlinghaus; Xia Li; E Brian Welch; Bapsi A Chakravarthy; John C Gore; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2011-09-28       Impact factor: 4.668

8.  Diffusion-weighted magnetic resonance imaging in focal breast lesions: analysis of 78 cases with pathological correlation.

Authors:  F Fornasa; L Pinali; A Gasparini; E Toniolli; S Montemezzi
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

9.  Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.

Authors:  Sana Parsian; Habib Rahbar; Kimberly H Allison; Wendy B Demartini; Matthew L Olson; Constance D Lehman; Savannah C Partridge
Journal:  Radiology       Date:  2012-10-02       Impact factor: 11.105

10.  Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.

Authors:  Lionel Mignion; Prasanta Dutta; Gary V Martinez; Parastou Foroutan; Robert J Gillies; Bénédicte F Jordan
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.